CorTec's implantable brain-computer interface is in clinical evaluation with two FDA Breakthrough Device Designations.
Published
Signal category
Legal & Regulatory
Quote
“Our implantable BCI is in clinical evaluation, now with two FDA Breakthrough Device Designations.”
— CorTec team
Company
CorTec
Fighting neurological conditions with implantable neurotechnology
- Industry
- Medical Equipment Manufacturing
- Location
- Freiburg, DE
- Company size
- 94 employees
CorTec is a German clinical-stage neurotechnology company, founded in 2010, with one purpose: to restore independence to people with neurological conditions. We build implantable systems that communicate directly with the nervous system. Our Brain Interchange™ platform, a fully implantable, bidirectional brain-computer interface (BCI), is now in clinical evaluation with patients, opening entirely new treatment modalities while gathering the data that, with AI, unlocks future therapies. We also provide implant technology to others in the global neurotherapy field, so together we can restore independence at a scale none of us could reach alone.
Founded 2010